264
Participants
Start Date
October 31, 2009
Primary Completion Date
October 31, 2013
Study Completion Date
January 31, 2014
N-acetylcysteine (NAC)
Participants will receive 600 mg of NAC three times a day.
Placebo
Participants will receive placebo each day.
Weill Medical College of Cornell University, New York
Mount Sinai Hospital, New York
Highland Hospital - University of Rochester Medical Center, Rochester
University of Pennsylvania Health System, Philadelphia
Temple University, Philadelphia
Duke Universtiy, Durham
Medical University of South Carolina, Charleston
University of Miami Miller School of Medicine, Miami
University of Alabama - Birmingham, Birmingham
Vanderbilt University, Nashville
University of Louisville, Louisville
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Mayo Clinic, Rochester
University of Chicago, Chicago
St. Luke's Hospital, Chesterfield
Tulane University, New Orleans
University of Texas Southwestern Medical Center, Dallas
National Jewish Medical and Research Center, Denver
University of Utah Health Research Center, Salt Lake City
University of California - Los Angeles, Los Angeles
University of California - San Francisco, San Francisco
University of Washington, Seattle
Yale University School of Medicine, New Haven
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke University
OTHER